Human receives AI-designed virus for the first time
The AI model Omnii-1, recently unveiled by the San Francisco-based AI lab Radical Numerics, was used to design viable bacteriophages for therapeutic use. These viruses target specific bacterial strains, offering potential advantages over antibiotics by preserving beneficial bacteria while combating antimicrobial-resistant infections. While phage therapy itself is not new, and AI has previously shown promise in phage engineering, this marks a claimed first for AI-designed phages administered to humans. The researchers have not yet disclosed results of the treatment.
Key points
- First reported human administration of AI-designed bacteriophage cocktail via compassionate-use program
- Designed using Omnii-1, Radical Numerics' new AI model for bioscience
- Phages target specific bacterial strains, offering alternative to broad-spectrum antibiotics
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. The Register did the reporting; read the original for the full story.
Read the full story at The Register
